Urea C 14

CHEMBL2096635 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
62.0 g/mol
LogP
-1.4
Phase
4

Urea C-14 is a radioactively labeled form of urea containing carbon-14 used in the 14C-urea breath test for non-invasive detection of Helicobacter pylori infection in the stomach. H. pylori-produced urease hydrolyzes the ingested 14C-urea to produce 14CO2, which is measured in exhaled breath by liquid scintillation counting, indicating active infection. Unlike the 13C version, the 14C test involves low-level radiation exposure, limiting use in pregnant women and children.

Молекулярная масса

62,0480 g/mol

LogP

-1,40

TPSA

69,10 Ų

Правило пяти Липинского

Соответствует

Терапевтические области

Механизм действия

Inhibits bacterial urease, the enzyme that hydrolyzes urea to ammonia and carbon dioxide, reducing the alkalinization of urine that promotes stone formation and infection persistence.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Inhibits bacterial urease, the enzyme that hydrolyzes urea to ammonia and carbon dioxide, reducing the alkalinization of urine that promotes stone formation and infection persistence.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N[14C](N)=O

InChI

InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)/i1+2

Molecular Formula

CH4N2O

HBD / HBA

2 / 1

Вращаемые Связи

0

Тяжёлые Атомы

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

Urea C-14 is a radioactively labeled form of urea containing carbon-14 used in the 14C-urea breath test for non-invasive detection of Helicobacter pylori infection in the stomach. H. pylori-produced urease hydrolyzes the ingested 14C-urea to produce 14CO2, which is measured in exhaled breath by liquid scintillation counting, indicating active infection. Unlike the 13C version, the 14C test involves low-level radiation exposure, limiting use in pregnant women and children.

Inhibits bacterial urease, the enzyme that hydrolyzes urea to ammonia and carbon dioxide, reducing the alkalinization of urine that promotes stone formation and infection persistence.

Yes, Urea C 14 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096635. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11457650. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.